pagelet_content
Tenon(R) Medical Announces Positive Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran(R) SI Joint Fusion System
Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint disorders, today announced significant progress in the post-market study utilizing the Company's Catamaran® SI Joint Fusion System.
Dr. Beacham for the 2024 Healthcare Hero Award
Dr. Beacham for the 2024 Healthcare Hero Award. The 2024 Healthcare Heroes will be featured in the March 1-7 edition of Louisville Business First and on the website.